Report Highlights
This report on defibrillators provides a brief description of the current status of the industry and recent developments. The report analyzes the market trends and rising opportunities in the developed and developing world.
Report Includes
- A brief general outlook of the global market for defibrillators
- Analysis of current and future market potential and discussion on the market drivers, challenges, and opportunities
- Analyses of global market trends with data from 2019-2022, and projections of compound annual growth rates (CAGRs) through 2027
- Segmentation of the defibrillators market by type, end use and region
- Insight into the recent industry structure, regulations and policies, pipeline products, and the vendor landscape of the market leading participants
Report Scope
The rising prevalence of cardiovascular diseases (CVDs) due to changed lifestyles has fueled the market for defibrillators. Lifestyle diseases such as hypertension, obesity, type 2 diabetes, and dyslipidemia are the major risk factors for CVD. CVD prevalence is also increasing due to the growing geriatric population, so the incidence of heart disease is expected to increase. During the last few years, significant improvements have been made in defibrillators. The development of subcutaneous implantable cardioverter-defibrillator (S-ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) is expected to drive market growth during the forecast period. High growth opportunities for defibrillators in emerging markets have also fueled the demand.
This report provides a brief exposure to the defibrillators global market. This report highlights the current and future market potential for this medical equipment and offers a brief analysis of the market's drivers, challenges, and opportunities. Revenues are broken down by region, type, and end user. For market estimates, data has been provided for 2019, 2020 and 2021 (as the base year), projections for 2022, and a forecast for 2027. The report also covers the market share for major market players. It includes the company profiles of the major players, with brief information about their business segments, financials, product portfolios, and recent developments. The report also provides an analysis of the impact of the COvID-19 pandemic on this market.
This report on defibrillators provides a brief description of the current status of the industry and recent developments. The report analyzes the market trends and identifies critical medical and geographical challenges and rising opportunities in the developed and developing world.
Report Synopsis
Report Metrics | Details | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Base year considered | 2021 | ||||||||||||
Forecast period considered | 2022 to 2027 | ||||||||||||
Base year market size | $14.1 billion | ||||||||||||
Market size forecast | $22.4 billion | ||||||||||||
Growth rate | CAGR of 8.2% during the forecast period of 2022-2027 | ||||||||||||
Units considered | $ Millions | ||||||||||||
Segments covered | By type, End-Use, and Region | ||||||||||||
Regions covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) | ||||||||||||
Key Market Drivers |
|
||||||||||||
Companies studied |
|
Frequently Asked Questions (FAQs)
- Increasing prevalence of cardiovascular diseases
- Technological advancements and innovations
- Growing aging population specially in Asia-Pacific region
- Increasing Government initiatives
- Increase in use of AEDs in public places
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Related Reports
Global Markets for Emerging Medical Device Technologies
The global market for emerging medical device technologies should grow from $81.9 billion in 2020 to $146.2 billion by 2025, at compound annual growth rate (CAGR) of 12.3% for the period of 2020-2025.
Cardiovascular Devices: Global Markets to 2022
The global market for cardiovascular devices reached nearly $42.4 billion in 2017 and should reach $59.1 billion by 2022, at a compound annual growth rate (CAGR) of 6.9% for the period of 2017-2022.
Recent Reports
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Direct-to-Consumer Genetic Testing: Global Markets and Technologies
The global market for DTC genetic testing is expected to grow from $2.3 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.0% during the forecast period of 2024 to 2029.
Global Medical Tapes Market
The global market for medical tapes is expected to grow from $5.6 billion in 2024 and is projected to reach $7.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 4.7% during the forecast period of 2024 to 2029.
Global Prenatal Testing Market
The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.
Global Skin Allergy Testing Market
The global market for skin allergy testing is expected to grow from $560 million in 2023 to $771.5 million by the end of 2028, at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2028.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More